New-Onset, But Not Chronic Atrial Fibrillation, Is a Significant Factor Contributing to Mortality Among Patients with Severe COVID-19

11 March 2025 : Clinical Research

Jakub Klimkiewicz

^1ABDEF*, Mateusz Gutowski

^1ABDE, Andrzej Michałowski^1ABDE, Kamil Paryż

^1ABDE, Anna Klimkiewicz^2ACDEF, Arkadiusz Lubas

^3ACDEF

DOI: 10.12659/MSM.946192

Med Sci Monit 2025; 31:e946192

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 1 Descriptive statistics of the examined population.

Variable	Mean or n	SD or %	Median	IQR

Age (years)	65.8	15	68	19
Female gender	140/334	41.9%
Male gender	194/334	58.1%

Obesity (BMI >35)	69/334	20.6%
Diabetes	85/334	25.4%
Hypertensio	191/334	57.1%
ischemic heart disease	53/334	15.9%
heart failure	37/334	11.1%
History of MI	23/334	6.9%
Cerebrovascular disorders	33/334	9.9%
Chronic kidney fisease	42/334	12.6%
Pulmonary embolism	22/334	6.5%

ALT (U/l)	77	256	37	35
AST (U/l)	109	45	45	41
CRP (mg/l)	10.5	8.3	8.9	11.8
Ferritin (mcg/l)	1510	2101	830	1183
WBC (10/l)	10.5	8.83	8.15	6.79
Urea (mg/dl)	68	57	49	56
Albumin (g/dl)	3	0.57	3	0.8
CT scan severity index (points)	14.7	6	15	10

Hospital stay (days)	11.8	8	10	9
Survival	217/334	65%
Deaths	117/334	35%
BMI – body mass index.

Back to the Article